Eiger BioPharmaceuticals, Inc.
EIGRQ · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13 | -$18 | -$21 | -$23 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $1 | $3 |
| Change in WC | -$2 | $2 | -$2 | -$4 |
| Other Non-Cash | $5 | $0 | $2 | $4 |
| Operating Cash Flow | -$14 | -$15 | -$22 | -$24 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$19 |
| Inv. Sales/Matur. | $12 | $19 | $30 | $33 |
| Other Inv. Act. | $12 | $19 | $30 | $14 |
| Investing Cash Flow | $12 | $19 | $30 | $13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | -$0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$0 | $0 |
| Financing Cash Flow | $0 | $0 | -$0 | $0 |
| Forex Effect | -$0 | $0 | $0 | -$0 |
| Net Chg. in Cash | -$2 | $5 | $8 | -$11 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $28 | $23 | $15 | $26 |
| End Cash | $25 | $28 | $23 | $15 |
| Free Cash Flow | -$14 | -$15 | -$22 | -$24 |